FDA Recall: Devices had an unapproved slabbing software function enabled for use

Company: FUJIFILM Healthcare Americas Corporation
Date of Enforcement Report: 7/30/2025
Class: II

PRODUCT

ASPRIRE Cristalle Mammography System (cleared under K212873) installed with the ASPIRE Cristalle Digital Breast Tomosynthesis (DBT) Option (approved under P160031)

Recall Number:

Z-2219-2025

REASON:

Devices had an unapproved slabbing software function enabled for use.

RECALLING FIRM/MANUFACTURER:

FUJIFILM Healthcare Americas Corporation

VOLUME:

293 units

DISTRIBUTION:

Worldwide distribution – US Nationwide and the countries of Canada, Chile, Ecuador.

About the author

Allison joined SoftwareCPR in 2022, bringing along over ten years of passion for building teamwork and growth in organizations. This is established in part by the greatest University the South has to offer- Mississippi State.

SoftwareCPR Training Courses:

IEC 62304 and other Emerging Standards Impacting Medical Device Software

Being Agile & Yet Compliant

ISO 14971 SaMD Risk Management

Software Risk Management

Medical Device Cybersecurity

Software Verification

IEC 62366 Usability Process and Documentation

Or just email training@softwarecpr.com for more info.

Corporate Office

15148 Springview St.
Tampa, FL 33624
USA
+1-781-721-2921
Partners located in the US (CA, FL, MA, MN, TX) and Canada.